CN106190993A - Avian influenza vaccine and the diagnostic antigen preparation method planting poison used - Google Patents
Avian influenza vaccine and the diagnostic antigen preparation method planting poison used Download PDFInfo
- Publication number
- CN106190993A CN106190993A CN201510502806.5A CN201510502806A CN106190993A CN 106190993 A CN106190993 A CN 106190993A CN 201510502806 A CN201510502806 A CN 201510502806A CN 106190993 A CN106190993 A CN 106190993A
- Authority
- CN
- China
- Prior art keywords
- avian influenza
- virus
- vaccine
- influenza vaccine
- diagnostic antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The present invention relates to veterinary biological product field, be used for preparing avian influenza vaccine and diagnostic antigen required kind poison.Present invention application Reverse Genetics, six, inside gene (PB2 with influenza virus cold adaptation strain, PB1, PA, NP, M, NS) it is genome skeleton, together with bird flu virus HA and NA gene, artificial constructed influenza virus, this virus is as preparing avian influenza vaccine and diagnostic antigen required kind poison, there is higher safety, and keep titer high, the advantages such as matching is strong, attenuated vaccine or the inactivated vaccine of preparation are safe and reliable, stronger immunity can be produced after immunity, can preventing bird flu effectively popular and propagating, reduce the economic loss that primary disease causes, reduce the threat to human health, there is important public health meaning, have broad application prospects.
Description
Technical field
The present invention relates to avian influenza vaccine and the diagnostic antigen preparation method planting poison used, belong to biological technical field.
Background technology
Bird flu (Avian influenza, AI) is a kind of poultry and the infectious disease of wild fowl caused by bird flu virus.Bird flu
Virus, according to hemagglutinin (HA) and the difference of neuraminidase (NA), can be divided into 16 HA hypotypes and 9 NA hypotypes.
High pathogenic avian influenza is the deadly infectious disease of the serious threat birds caused by some H5 or H7 subtype avian influenza virus.Some
High pathogenic avian influenza virus can also cause the infection of people, morbidity, even dead.
Since 2003, the H5N1 subtype highly pathogenic avian influenza multiple countries and regions including China always are popular,
Not only causing serious economic loss to aviculture, the health of the mankind in also serious threat.Except constantly strengthening and improving influenza
Beyond monitoring, vaccine remains the important means of prevention and control AI.2005, it is extensive strong that China comes into effect for bird flu
Property immunity policy processed, and achieve remarkable effect.Along with the continuous variation of virus, vaccine also updates Re-4 and Re-5 from Re-1,
Re-6 and Re-7 up till now.All these vaccines are all six internal gene by PR8 (A/PR/8/34) and popular poison
Two external gene restructuring of HA and NA of strain form.Due to the PR8 virus high-affinity to mammal, for safety
Considering, these vaccines that all PR8 recombinate and come can only be made inactivated vaccine and use.Inactivated vaccine is mainly produced by induction of antibodies
Protection body can be accelerated in antibody mediated immunity pressure lower variation speed from virus attack, virus from birth so that virus is more difficult to prevention
And control.This patent provides a kind of new avian influenza vaccine and the diagnostic antigen preparation method planting poison used.Plant poison, as epidemic disease
" seed " that Seedling produces, is the key point of production of vaccine.Supporting diagnostic antigen is that vaccine quality controls and vaccine using effect
The necessary material evaluated, and planting poison is supporting hemagglutination test or the necessary material of hemagglutination inhibition test diagnostic antigen production.
Summary of the invention
This patent determine with first cold adaptation influenzae strain virus A/Ann Arbor/6/60 (AAca) six internal gene (PB2,
PB1, PA, NP, M and NS) and the external gene (HA and NA) of epidemic isolates, by reverse genetics manipulation technology,
Avian influenza vaccine and diagnostic antigen required kind poison.Reverse genetics manipulation technology refers to by certain or some artificial constructed plasmids,
Transfect specific cell, produce a kind of technology of the desired virus obtained.Utilize cold adaptation influenzae strain virus A/Ann
Arbor/6/60 (AAca) and Reverse Genetics prepare avian influenza vaccine and the required poison of planting of diagnostic antigen has higher safety,
And keeping the advantages such as titer is high, matching is strong, attenuated vaccine or the inactivated vaccine of preparation are safe and reliable, can produce relatively after immunity
Strong immunity, it is possible to the popular and propagation of preventing bird flu effectively, reduces the economic loss that primary disease causes, reduces human health
Threat, there is important public health meaning, have broad application prospects.
This patent determines first prepares six internal gene sequences of required viral backbone during avian influenza vaccine with Reverse Genetics
Row.
Detailed description of the invention
Below by embodiment, further illustrate technical scheme, but protection scope of the present invention is not limited to this.
The recombiant plasmid of expression A/Ann Arbor/6/60 (AAca) six internal gene of virus described in embodiment is moved by China
Thing health preserves with epidemiology center construction, and 293T cell is purchased from QbioGene company;Liposome Lipofectamine2000
Purchased from Invitrogen company.
Embodiment 1
The construction method of restructuring H5 subtype avian influenza virus (rH5/AAca), comprises the steps:
1, synthetic and six internal gene of clone A/Ann Arbor/6/60 (AAca)
PB2, PB1, PA, NP, M, NS gene order (SEQ ID NO.1~NO.6) specified according to the present invention, adopts
By the method for synthetic, insert it in bi-directional expression vector (can simultaneously transcribe generation viral RNA and mRNA),
Prepare pH-PB2, pH-PB1, pH-PA, pH-NP, pH-M, pH-NS plasmid.
2, the clone of H5 subtype avian influenza virus surface gene
Amplification H5 subtype avian influenza virus HA and NA surface gene, and HA gene is carried out molecular modification, remove and H5
The multiple basic amino acids at HA protein cleavage site that subtype avian influenza virus pathogenicity is relevant so that it is obtain low pathogenicity fowl
The characterization of molecules of influenza virus (will-PLRERRRKR-sport-PQRETR-), inserts it in bi-directional expression vector,
Prepare pH-mHA and plasmid pH-NA.
3, the restructuring packaging of H5 subtype avian influenza virus and qualification
Express 6 internal gene recombinant expression plasmids of A/Ann Arbor/6/60 (AAca) virus, with expression H5 hypotype fowl
Influenza virus HA and NA gene recombination plasmid, through liposome Lipofectamine 2000 cotransfection 293T cell.Will transfection
Cell is inoculated in 10 age in days SPF Embryo Gallus domesticus, every embryo 0.1mL, two embryos of each sample inoculation through allantoic cavity, puts 35 DEG C and cultivates extremely
72h, collects allantoic fluid, and the standard recommended with International Office of Epizootics (OIE) carries out blood clotting (HA) and blood clotting suppression (HI) examination
Test identifying virus.HI positive allantoic fluid, the 2nd generation allantoic fluid passed on Embryo Gallus domesticus extract RNA, RT-PCR amplification HA and
NS genetic fragment checks order.Expand without the RNA PCR of reverse transcription.RT-PCR amplification and sequencing result show, save
The virus rescued is restructuring H5 subtype avian influenza virus, without the RNA PCR of reverse transcription without amplified band.Obtain restructuring disease
The named rH5/AAca of poison.
4, the enrichment procedure of virus needed for production of vaccine
With physiological saline solution 1: 10000 times dilution rH5/AAca virus, inoculate 10 age in days SPF Embryo Gallus domesticus, 0.1mL/ through allantoic cavity
Embryo, the survival chick embryo allantoic liquid after results cultivation 72h, measure HA titer, virus allantoic fluid HA titer is 29, and aseptic
It is qualified to check.
5, the virus inactivating method needed for production of vaccine
By addition formalin in the allantoic fluid of results to final concentration 0.2%, 2-8 DEG C of inactivation 48h, shake up once every 2h.Go out
Living after 48h, each virus sample 10 pieces of Embryo Gallus domesticus of inoculation, every embryo 0.1mL, mensuration HA titer after hatching 72h, without coagulation
An allantoic fluid blind passage generation again.The second filial generation is still judged to virus complete inactivation without coagulation.Result virus allantoic fluid Embryo Gallus domesticus passes on 2 times
All coagulation without producing, inactivation is completely.
6, the quality testing of inactivated vaccine
Prepared rH5/AAca strain oil emulsion inactivated vaccine by the method for " veterinary biological product code " and carried out the aseptic examination of vaccine
Test, physical behavior, safety detection.Indices meets the regulation of " veterinary biological product code ".
7, the immuning effect test of vaccine
50 21 age in days SPF chickens are randomly divided into 5 groups, often group 10.1-4 group intramuscular inoculation quality testing is qualified
RH5/AAca avian influenza vaccine, immunizing dose is respectively 0.05,0.1,0.3,0.5mL/ only, the 5th group is blank group,
Isolated rearing.After immunity 2 weeks and 3 weeks, blood sampling measured H5 subtype avian influenza virus antibody horizontal.Within after immunity 3 weeks, use homology
H5 subtype highly pathogenic avian influenza virus counteracting toxic substances, it is determined that the immune protective effect (table 1) of vaccine.
The result of the test that affects of immune efficacy is shown by the different immunizing doses of H5 subtype avian influenza virus inactivated vaccine, is developed
Vaccine immunity dosage be that 0.1mL/ only just can make vaccinated flock within 3 weeks after immunity, be obtained with the protection viral to H5.From
From the point of view of antibody generation level, the antibody horizontal of 0.3mL/ immunizing dose group chicken is apparently higher than 0.1mL group, and 0.3mL group resists
Body remained stable rises.Multiple comparisons shows, 0.3 is not notable (P > 0.05) with 0.5mL group antibody titer change difference,
Illustrate under similarity condition, to select 0.3mL/ dose inoculation can reach effect of preferably preventing epidemic.
Table 1 is recombinated the immuning effect test of H5 subtype avian influenza virus oil emulsion inactivated vaccine
Note: * denominator represents test chicken number, molecule represents dead chicken number.
8, H5 subtype avian influenza virus is as the method for diagnostic antigen
The enrichment procedure of H5 subtype avian influenza virus is with step 4.The enrichment procedure of H5 subtype avian influenza virus is with step 4, inactivation
Method is with step 5.Carry out hemagglutination inhibition test with this inactivation of viruses and detect the immune effect of vaccine (HI antibody titer) matched,
As shown in step 7.
SEQUENCE LISTING
<110>China Animal Health and Epidemiology Center
<120>avian influenza vaccine and the diagnostic antigen preparation method planting poison used
<160> 6
<170> PatentIn version 3.3
<210> 1
<211> 2341
<212> DNA
<213> Influenza virus
<400> 1
agcgaaagca ggtcaattat attcaatatg gaaagaataa aagaactacg
gaatctgatg 60
tcgcagtctc gcactcgcga gatactaaca aaaaccacag tggaccatat
ggccataatt 120
aagaagtaca catcagggag acaggaaaag aacccgtcac ttaggatgaa
atggatgatg 180
gcaatgaaat atccgattac agccgacaag aggataacag aaatgattcc
tgagagaaat 240
gagcaagggc aaactctatg gagtaaaatg agtgatgccg gatcggatcg
tgtgatggta 300
tcacctctgg ctgtgacatg gtggaataga aatggaccaa tgacaagtac
ggttcattat 360
ccaaaaatct acaaaactta ttttgagaaa gtcgaaaggt taaaacatgg
aacctttggc 420
cctgttcatt ttagaaacca agtcaaaata cgccgaagag ttgacataaa
tcctggtcat 480
gcagacctca gtgccaagga ggcacaggat gtaatcatgg aagttgtttt
ccctaacgaa 540
gtgggggcca ggatactaac gtcggaatcg caattaacaa taaccaaaga
gaaaaaagaa 600
gaactccagg attgcaaaat ttcacctttg atggttgcgt acatgttaga
gagagaactt 660
gtccgaaaaa cgagatttct cccagttgct ggtggaacaa gcagtgtgta
catcgaagtg 720
ttgcacttga ctcaaggaac atgctgggaa cagatgtaca ctccaggtgg
agaagtgagg 780
aatgatgatg ttgatcaaag tctaattatt gcagccagga gcatagtgag aagagcagca
840
gtatcagcag atccactagc atctttattg gagatgtgcc acagcacaca
gattggcggg 900
acaaggatgg tggacattct taggcagaac ccaacagaag agcaagctgt
ggaaatatgc 960
aaagctgcaa tgggactgag gatcagctca tccttcagtt ttggcgggtt
cacatttaag 1020
agaacaagcg gatcatcagt caagagagag gaagaagtgc ttacgggcaa
tcttcaaaca 1080
ttgaaaataa gggtgcatga gggatacgag gagttcacaa tggttgggaa
aagggcaaca 1140
gctatactca gaaaagcaac caggagattg attcagctga tagtgagtgg
aagagacgaa 1200
cagtcgatag ccgaagcaat aattgtggcc atggtatttt cacaagaaga
ttgtatgata 1260
aaagcagtta gaggtgatct gaatttcgtt aatagggcaa atcagcgatt
gaatcccatg 1320
catcaacttt taagacattt tcagaaggat gctaaagtgc tttttcaaaa
ttggggaatt 1380
gaacatatcg acaatgtgat gggaatgatt ggggtattac cagacatgac
tccaagcaca 1440
gagatgtcaa tgagaggggt aagagtcagc aaaatgggcg tagatgaata
ctccagcgcg 1500
gagagagtag tggtgagcat tgaccggttt ttgagagttc gagaccaacg
aggaaatgta 1560
ctactatctc ctgaggaggt cagtgaaaca cagggaacag agaaactgac
aataacttac 1620
tcatcgtcaa tgatgtggga gattaatggc cctgagtcag tgttggtcaa
tacctatcag 1680
tggatcatca gaaactggga aactgttaaa attcagtggt ctcagaatcc
tacaatgcta 1740
tacaataaaa tggaatttga gccatttcag tctttagttc ctaaggccat
tagaggccaa 1800
tacagtgggt ttgttaggac tctattccaa caaatgaggg atgtacttgg gacatttgat
1860
accacccaga taataaaact tcttcccttt gcagccgccc caccaaagca
aagtagaatg 1920
caattctctt cattgactgt gaatgtgagg ggatcaggaa tgagaatact
tgtaaggggc 1980
aattctccta tattcaacta caacaagacc actaagagac taacaattct
cggaaaggat 2040
gctggcactt taactgaaga cccagatgaa ggcacatctg gagtggagtc
cgctgttctg 2100
agaggattcc tcattctggg caaagaagat aggagatatg gaccagcatt
aagcatcaat 2160
gaactgagta accttgcgaa aggagaaaag gctaatgtac taattgggca
aggagacgtg 2220
gtgttggtaa tgaaacgaaa acggaactct agcatactta ctgacagcca
gacagcgacc 2280
aaaaggattc ggatggccat caattaatgt tgaatagttt aaaaacgacc
ttgtttctac 2340
t
2341
<210> 2
<211> 2341
<212> DNA
<213> Influenza virus
<400> 2
agcgaaagca ggcaaaccat ttgaatggat gtcaatccga ccttactttt
cttgaaagtt 60
ccagcgcaaa atgccataag tactacattc ccttatactg gagatcctcc
atacagccat 120
ggaacaggaa caggatacac catggacaca gtcaacagaa cacatcaata
ttcagaaaag 180
gggaagtgga caacaaacac ggaaactgga gcgcaccaac ttaacccaat
tgatggacca 240
ctacctgagg acaatgaacc aagtggatat gcacaaacag actgcgtcct
ggaagcaatg 300
gctttccttg aagaatccca cccaggaatc tttgaaaact cgtgtcttga
aacgatggaa 360
gttattcaac aaacaagagt ggacaaactg acccaaggtc gtcagaccta
tgattggaca 420
ttgaacagaa atcagccggc tgcaactgcg ctagccaaca ctatagaggt
cttcagatcg 480
aatggcctga cagctaatga atcgggaagg ctaatagatt tcctcaagga
tgtgatagaa 540
tcaatggata aagaggagat ggaaatcaca acacacttcc aaagaaaaag
aagagtaaga 600
gacaacatga ccaagaaaat ggtcacacaa cgaacaatag gaaagaagaa
gcaaagattg 660
aacaagagaa gctatctaat aagagcactg acattgaaca caatgactaa
agatgcagag 720
agaggtaaat taaagagaag agcaattgca acacccggta tgcagatcag
agggttcgtg 780
tactttgtcg aaacactagc gagaagtatt tgtgagaagc ttgaacagtc
tgggcttccg 840
gttggaggta atgaaaagaa ggctaaactg gcaaatgttg tgcgaaaaat
gatgactaat 900
tcacaagaca cagagctctc tttcacaatt actggagaca ataccaaatg
gaatgagaat 960
caaaatcctc ggatgttcct ggcgatgata acatacatca caagaaatca
acctgaatgg 1020
tttagaaacg tcctgagcat cgcacctata atgttctcaa ataaaatggc
aagactaggg 1080
aaaggataca tgttcaaaag caagagcatg aagctccgaa cacaaatacc
agcagaaatg 1140
ctagcaagta ttgacctgaa atactttaat gaatcaacaa gaaagaaaat
cgaggaaata 1200
aggcctctcc taatagatgg cacagtctca ttgagtcctg gaatgatgat
gggcatgttc 1260
aacatgctaa gtacagtctt aggagtctca atcctgaatc ttggacaaaa
gaagtacacc 1320
aaaacaacat actggtggga cggactccaa tcctctgatg acttcgccct
catagtgaat 1380
gcaccaaatc atgagggaat acaagcaggg gtggatagat tctacagaac
ctgcaagcta 1440
gtcggaatca atatgagcaa aaagaagtcc tacataaata ggacagggac
atttgaattc 1500
acaagctttt tctatcgcta tggatttgta gccaatttta gcatggagct
gcccagcttt 1560
ggagtgtctg gaattaatga atcggctgat atgagcattg gggtaacagt
gataaagaac 1620
aacatgataa acaatgacct tgggccagca acagcccaac tggctcttca
actattcatc 1680
aaagactaca gatatacgta ccggtgccac agaggagaca cacaaattca
gacaaggaga 1740
tcattcgagc taaagaagct gtgggggcaa acccgctcaa aggcaggact
tttggtttcg 1800
gatggaggac caaacttata caatatccgg aatctccaca ttccagaagt
ctgcttgaag 1860
tgggagctaa tggatgaaga ctatcagggg aggctttgta atcccctgaa
tccatttgtc 1920
agtcataagg agattgagtc tgtaaacaat gctgtggtaa tgccagctca cggtccagcc
1980
aagagcatgg aatatgatgc tgttactact acacactcct ggatccctaa
gaggaaccgc 2040
tccattctca acacaagcca aaggggaatt cttgaagatg aacagatgta
tcagaagtgt 2100
tgcaatctat tcgagaaatt cttccctagc agttcgtaca ggagaccagt
tggaatttcc 2160
agcatggtgg aggccatggt gtctagggcc cggattgatg cacggattga
cttcgagtct 2220
ggacggatta agaaagagga gttcgctgag atcatgaaga tctgttccac
cattgaagag 2280
ctcagacggc aaaaatagtg aatttagctt gtccttcatg aaaaaatgcc
ttgtttctac 2340
t
2341
<210> 3
<211> 2233
<212> DNA
<213> Influenza virus
<400> 3
agcgaaagca ggtactgatt cgaaatggaa gattttgtgc gacaatgctt
caatccgatg 60
attgtcgagc ttgcggaaaa agcaatgaaa gagtatggag aggatctgaa
aatcgaaaca 120
aacaaatttg cagcaatatg cactcacttg gaagtatgct tcatgtattc
agattttcat 180
ttcatcaatg agcaaggcga gtcaataata gtagagcttg atgatccaaa
tgcacttttg 240
aagcacagat ttgaaataat agagggaaga gatcgcacaa tggcctggac
agtagtaaac 300
agtatttgca acactacagg agctgagaaa ccgaagtttc tgccagattt
gtatgattac 360
aaggagaata gattcatcga gattggagtg acaaggaggg aagtccacat
atactatctt 420
gaaaaggcca ataaaattaa atctgagaag acacacatcc acattttctc
attcactggg 480
gaagaaatgg ccacaaaggc cgactacact ctcgatgagg aaagcagggc
taggatcaaa 540
accagactat tcaccataag acaagaaatg gctagcagag gcctctggga
ttcctttcat 600
cagtccgaaa gaggcgaaga aacaattgaa gaaagatttg aaatcacagg
gacaatgcgc 660
aggctcgccg accaaagtct cccgccgaac ttctcctgcc ttgagaattt
tagagcctat 720
gtggatggat tcgaaccgaa cggctacatt gagggcaagc tttctcaaat
gtccaaagaa 780
gtaaatgcta aaattgaacc ttttctgaaa acaacaccaa gaccaattag
acttccggat 840
gggcctcctt gttctcagcg gtccaaattc ctgctgatgg atgctttaaa
attaagcatt 900
gaggacccaa gtcacgaagg agagggaata ccactatatg atgcgatcaa
gtgtatgaga 960
acattctttg gatggaaaga accctatgtt gttaaaccac acgaaaaggg
aataaatcca 1020
aattatctgc tgtcatggaa gcaagtactg gcagaactgc aggacattga
gaatgaggag 1080
aagattccaa gaaccaaaaa catgaagaaa acgagtcagc taaagtgggc
acttggtgag 1140
aacatggcac cagagaaggt agactttgac gactgtagag atgtaagcga
tttgaagcaa 1200
tatgatagtg atgaacctga attaaggtca ctttcaagct ggatccagaa
tgagttcaac 1260
aaggcatgcg agctgaccga ttcaatctgg atagagctcg atgagattgg
agaagatgtg 1320
gctccaattg aacacattgc aagcatgaga aggaattact tcacagcaga
ggtgtctcat 1380
tgcagagcca cagaatatat aatgaagggg gtatacatta atactgcctt
gcttaatgca 1440
tcctgtgcag caatggacga tttccaacta attcccatga taagcaaatg
tagaactaaa 1500
gagggaaggc gaaagaccaa tttatatggt ttcatcataa aaggaagatc
tcacttaagg 1560
aatgacaccg acgtggtaaa ctttgtgagc atggagtttt ctctcactga
cccaagactt 1620
gagccacaca aatgggagaa gtactgtgtt cttgagatag gagatatgct
actaagaagt 1680
gccataggcc aggtgtcaag gcccatgttc ttgtatgtga ggacaaatgg
aacatcaaag 1740
attaaaatga aatggggaat ggagatgagg cgttgcctcc ttcagtcact
ccaacaaatc 1800
gagagtatga ttgaagccga gtcctctgtc aaggagaaag acatgaccaa
agagtttttc 1860
aagaataaat cagaaacatg gcccattgga gagtccccca aaggagtgga
agaaggttcc 1920
attgggaagg tctgcaggac tttattagcc aagtcggtat tcaatagcct
gtatgcatct 1980
ccacaattag aaggattttc agctgaatca agaaaactgc ttcttgtcgt
tcaggctctt 2040
agggacaatc ttgaacctgg gacctttgat cttggggggc tatatgaagc
aattgaggag 2100
tgcctgatta atgatccctg ggttttgctt aatgcgtctt ggttcaactc
cttcctaaca 2160
catgcattaa gatagttgtg gcaatgctac tatttgctat ccatactgtc
caaaaaagta 2220
ccttgtttct
act
2233
<210> 4
<211> 1566
<212> DNA
<213> Influenza virus
<400> 4
agcgaaagca gggtagataa tcactcactg agtgacatca aaatcatggc
gtcccaaggc 60
accaaacggt cttatgaaca gatggaaact gatggggaac gccagaatgc
aaatgaaatc 120
agagcatccg tcgggaagat gattggtgga attggacgat tctacatcca
aatgtgcacc 180
gaacttaaac tcagtgatta tgaggggcgg ctgatccaga acagcttaac
aatagagaga 240
atggtgctct ctgcttttga cgagaggagg aataaatatc tggaagaaca
tcccagcgcg 300
gggaaggatc ctaagaaaac tggaggaccc atatacaaga gagtagatgg
aaagtggatg 360
agggaactcg tcctttatga caaagaagaa ataaggcgaa tctggcgcca
agctaataat 420
ggtgatgatg caacagctgg tctgactcac atgatgatct ggcattccaa
tttgaatgat 480
acaacatacc agaggacaag agctcttgtt cgcaccggaa tggatcccag
gatgtgctct 540
ttgatgcagg gttcgactct ccctaggagg tctggagccg caggcgctgc
agtcaaagga 600
gttgggacaa tggtgatgga gttgataagg atgatcaaac gtgggatcaa
tgatcggaac 660
ttctggagag gtgagaatgg gcggaaaaca aggaatgctt atgagagaat
gtgcaacatt 720
ctcaaaggaa aatttcaaac agctgcacaa agagcaatga tggatcaagt
gagagaaagc 780
cggaacccag gaaatgctga gatcgaagat ctcatctttc tggcacggtc
tgcactcata 840
ttgagagggt cagttgctca caaatcttgt ctgcctgcct gtgtgtatgg
acctgccgta 900
gccagtggct acgacttcga aaaagaggga tactctttag tagggataga
ccctttcaaa 960
ctgcttcaaa acagccaagt atacagccta atcagaccga atgagaatcc
agcacacaag 1020
agtcagctgg tgtggatggc atgcaattct gctgcatttg aagatctaag
agtatcaagc 1080
ttcatcagag ggaccaaagt aatcccaagg gggaaacttt ccactagagg
agtacaaatt 1140
gcttcaaatg aaaacatgga tactatggga tcaagtactc ttgaactgag
aagcaggtac 1200
tgggccataa ggaccagaag tggaggaaac actaatcaac agagggcctc
tgcaggtcaa 1260
atcagtgtac aacctacgtt ttctgtgcaa agaaacctcc catttgacaa
accaaccatc 1320
atggcagcat tcactgggaa tgcagaggga agaacatcag acatgagggc
agaaatcata 1380
aggatgatgg aaggtgcaaa accagaagaa gtgtccttcc aggggcgggg
agtcttcgag 1440
ctctcggacg aaaaggcaac gaacccgatc gtgccctctt ttgacatgag
taatgaagga 1500
tcttatttct tcggagacaa tgcagaggag tacgacaatt aaggaaaaaa
tacccttgtt 1560
tctact
1566
<210> 5
<211> 1027
<212> DNA
<213> Influenza virus
<400> 5
agcgaaagca ggtagatatt gaaagatgag tcttctaacc gaggtcgaaa
cgtacgttct 60
ctctatcatc ccgtcaggcc ccctcaaagc cgagatcgca cagagacttg
aagatgtctt 120
tgctgggaaa aacaccgatc ttgaggctct catggaatgg ctaaagacaa
gaccaatcct 180
gtcacctctg actaagggga ttttgggatt tgtattcacg ctcaccgtgc
ccagtgagcg 240
aggactgcag cgtagacgct ttgtccaaaa tgccctcaat gggaatgggg
atccaaataa 300
catggacaga gcagttaaac tgtatagaaa gcttaagagg gagataacat
tccatggggc 360
caaagaaata gcgctcagtt attctgctgg tgcacttgcc agttgtatgg
gcctcatata 420
caacaggatg ggggctgtga ccactgaagt ggtcttaggc ctggtatgtg
caacctgtga 480
acagattgct gactcccagc ataggtctca taggcaaatg gtgacaacaa
ccaatccact 540
aataagacat gagaacagaa tggttctggc cagcactaca gctaaggcta
tggagcaaat 600
ggctggatcg agtgagcaag cagcagaggc catggaggtt gctagtcagg
ccaggcaaat 660
ggtgcaggca atgagagtta ttgggactca tcctagctcc agtgctggtc
taaaaaatga 720
tcttcttgaa aatttgcagg cctatcagaa acgaatgggg gtgcagatgc
aacgattcaa 780
gtgaccctct tgttgttgcc gcgagtatca ttgggatctt gcacttgata
ttgtggattc 840
ttgatcatct ttttttcaaa tgcatttatc gcttctttaa acacggtctg
aaaagagggc 900
cttctacgga aggagtacca gagtctatga gggaagaata tcgaaaggaa
cagcagagtg 960
ctgtggatgc tgacgatagt cattttgtca gcatagagct ggagtaaaaa
actaccttgt 1020
ttctact
1027
<210> 6
<211> 890
<212> DNA
<213> Influenza virus
<400> 6
agcgaaagca gggtgacaaa gacataatgg atcctaacac tgtgtcaagc
tttcaggtag 60
attgcttcct ttggcatgtc cgcaaacaag ttgcagacca agaactaggt
gatgccccat 120
tccttgatcg gcttcgccga gatcagaagt ccctaagggg aagaggcagt
actctcggtc 180
tgaacatcga aacagccacc cgtgttggaa agcagatagt ggagaggatt
ctgaaggaag 240
aatccgatga ggcacttaaa atgaccatgg cctccgcacc tgcttcgcga
tacctaactg 300
acatgactat tgaggaaatg tcaagggact ggttcatgct aatgcccaag
cagaaagtgg 360
caggccctct ttgtatcaga atggaccagg caatcatgga taagaacatc
atattgaaag 420
cgaatttcag tgtgattttt gaccggctag agaccctaat attactaagg
gctttcaccg 480
aagcgggagc aattgttggc gaaatttcac cattgccttc tcttccagga
catactaatg 540
aggatgtcaa aaatgcaatt ggggtcctca tcggaggact tgaatggaat
gataacacag 600
ttcgagtctc taaaactcta cagagattcg cttggagaag cagtgatgag
aatgggagac 660
ctccactcac tccaaaatag aaacggaaaa tggcgagaac aattaggtca
aaagttcgaa 720
gaaataagat ggctgattga agaagtgaga cacaaattga agataacaga
gaatagtttt 780
gagcaaataa catttatgca agccttacag ctactatttg aagtggaaca
agagataaga 840
actttctcgt ttcagcttat ttaatgataa aaaacaccct
tgtttctact
890
Claims (5)
1. with Reverse Genetics and cold adaptation influenzae strain viral backbone, artificial constructed influenza virus, the kind poison produced as avian influenza vaccine.
Plant poison the most as claimed in claim 1, it is characterized in that, described bird flu virus PB2, PB1, PA, NP, M, NS gene order and SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3, SEQ ID NO.4, SEQ ID NO.5, SEQ ID NO.6 similarity (similarity) are higher than 95%.
3. the kind poison described in claim 2, for avian influenza vaccine or the production of supporting diagnostic antigen.
4. the kind poison described in claim 2, for H5 subtype avian influenza vaccine or the production of supporting diagnostic reagent.
5. the kind poison described in claim 2, for H7 subtype avian influenza vaccine or the production of supporting diagnostic reagent.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510152425 | 2015-04-02 | ||
CN2015101524259 | 2015-04-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106190993A true CN106190993A (en) | 2016-12-07 |
Family
ID=57453094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510502806.5A Pending CN106190993A (en) | 2015-04-02 | 2015-08-17 | Avian influenza vaccine and the diagnostic antigen preparation method planting poison used |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106190993A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107064499A (en) * | 2017-03-15 | 2017-08-18 | 青岛蔚蓝生物制品有限公司 | Avian influenza virus nucleoprotein antigen epitope polypeptide and its colloid gold test paper box |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1810961A (en) * | 2006-02-22 | 2006-08-02 | 中国人民解放军军事医学科学院微生物流行病研究所 | Recombinant influenza virus and its prepn and application |
CN101780275A (en) * | 2009-01-21 | 2010-07-21 | 中国农业科学院哈尔滨兽医研究所 | Development of H5N1 subtype avian influenza cold-adaption attenuated live vaccines and application thereof |
-
2015
- 2015-08-17 CN CN201510502806.5A patent/CN106190993A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1810961A (en) * | 2006-02-22 | 2006-08-02 | 中国人民解放军军事医学科学院微生物流行病研究所 | Recombinant influenza virus and its prepn and application |
CN101780275A (en) * | 2009-01-21 | 2010-07-21 | 中国农业科学院哈尔滨兽医研究所 | Development of H5N1 subtype avian influenza cold-adaption attenuated live vaccines and application thereof |
Non-Patent Citations (1)
Title |
---|
叶艺: ""A型流感病毒冷适应株的拯救及免疫原性的初步研究"", 《中国优秀硕士学位论文全文数据库(电子期刊)医药卫生科技辑》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107064499A (en) * | 2017-03-15 | 2017-08-18 | 青岛蔚蓝生物制品有限公司 | Avian influenza virus nucleoprotein antigen epitope polypeptide and its colloid gold test paper box |
CN107064499B (en) * | 2017-03-15 | 2019-06-18 | 青岛蔚蓝生物制品有限公司 | Avian influenza virus nucleoprotein antigen epitope polypeptide and its colloid gold test paper box |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10808229B2 (en) | High titer recombinant influenza viruses with enhanced replication in vero cells | |
CN101472941B (en) | High titer recombinant influenza viruses for vaccine | |
US10172934B2 (en) | High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs | |
KR102080914B1 (en) | Influenza virus mutants and uses therefor | |
US10246686B2 (en) | Influenza virus replication for vaccine development | |
CN102304495A (en) | Recombinant influenza virus capable of expressing HA (hemagglutinin) protein with high efficiency and preparation method and application thereof | |
CN108913701B (en) | Method for improving multiplication titer of H7N9 subtype avian influenza vaccine strain | |
CN101780275A (en) | Development of H5N1 subtype avian influenza cold-adaption attenuated live vaccines and application thereof | |
US20240010995A1 (en) | Recombinant influenza viruses with stabilized na | |
US20220202927A1 (en) | Recombinant influenza viruses with stabilized ha for replication in eggs | |
US11390649B2 (en) | Influenza virus replication for vaccine development | |
CN108018300A (en) | Distinguish immune and infection animal H7 subtype avian influenza vaccine strains and its preparation method and application | |
KR101835989B1 (en) | Recombinant influenza virus to form cross-protection against multiple subtypes h3 and h7 of influenza viruses and vaccine comprising the same | |
KR101879936B1 (en) | Novel H5N9 recombinant influenza virus and vaccine composition comprising the same | |
EP3715459B1 (en) | H9 avian influenza vaccine strain which differentiates infected from vaccinated animals, and preparation method therefor | |
CN106190993A (en) | Avian influenza vaccine and the diagnostic antigen preparation method planting poison used | |
CN101947317B (en) | Large-scale preparation method of H5N1 avian influenza virus-like particle vaccines | |
KR20110131735A (en) | Recombinant swine influenza a virus comprising the gene of a/korea/cj01/09 and a/puerto rico/08/34, and the swine influenza a virus vaccine comprising the same | |
CN104109655B (en) | Kind of malicious preparation method needed for H7 subtype avian influenzas vaccine and diagnostic reagent | |
CN108103084A (en) | Distinguish immune and infection animal H5 subtype avian influenza vaccine strains and its preparation method and application | |
RU2606019C1 (en) | Vaccine influenza virus strain a/17/hongkong/2014/8296 (h3n2) for preparing live influenza intranasal vaccine for adults and children | |
US11214799B2 (en) | HA-specific influenza virus attenuated vaccine comprising mutations in segment 7, and uses therefor | |
CN111269895B (en) | Influenza a virus attenuated strain and application thereof as framework virus and vaccine | |
KR101857863B1 (en) | Novel H5N9 recombinant influenza virus and vaccine composition comprising the same | |
KR101481986B1 (en) | Live vaccine protecting against pathogenic avian influenza H5N1 and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161207 |
|
WD01 | Invention patent application deemed withdrawn after publication |